Aryloxypropanolamine beta 3 adrenergic agonists

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 217/58 (2006.01) A61K 31/135 (2006.01) A61K 31/18 (2006.01) A61K 31/36 (2006.01) A61K 31/41 (2006.01) C07C 217/30 (2006.01) C07C 217/84 (2006.01) C07C 217/86 (2006.01) C07C 237/30 (2006.01) C07C 311/13 (2006.01) C07C 317/32 (2006.01) C07D 209/42 (2006.01) C07D 215/227 (2006.01) C07D 215/26 (2006.01) C07D 235/26 (2006.01) C07D 249/18 (2006.01) C07D 263/58 (2006.01) C07D 317/58 (2006.01) C07D 405/12 (2006.01)

Patent

CA 2164246

Compounds of the formula I Image and pharmaceutically acceptable salts thereof wherein: R1 to R9 are as defined herein and m is the integer 0 or 1. These compounds are beta 3 adrenergic receptor agonists and are useful, therefore for example, in the treatment of diabetes, obesity, gastrointestinal diseases and achalasia.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Aryloxypropanolamine beta 3 adrenergic agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aryloxypropanolamine beta 3 adrenergic agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryloxypropanolamine beta 3 adrenergic agonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1811737

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.